Chronic heart failure in adults: diagnosis and management
KEYWORDS: heart, failure, heart failure, people, ejection, fraction, ejection fraction, reduced, recommendations, committee, reduced ejection, person, inhibitor, specialist, care

the person's heart failure and think about investigating for alternative causes. [2025] For a short explanation of why the committee made these recommendations and how they might affect practice, see the rationale and impact section on IV iron therapy for heart failure with reduced ejection fraction. Full details of the evidence and the committee's discussion are in evidence review C: IV iron therapy for heart failure. Specialist treatment Ivabradine 1.4.8 Ivabradine is recommended as an option in NICE technology appraisal guidance for treating heart failure with reduced ejection fraction. For full details, see the guidance on ivabradine (TA267, 2012). Hydralazine in combination with nitrate 1.4.9 If ACE inhibitors, ARNIs and ARBs are not tolerated, seek specialist advice and consider hydralazine in combination with nitrate. [2010, amended 2025] 1.4.10 Seek specialist advice about whether to offer hydralazine in combination with nitrate (especially if the person is of African or Caribbean ethnicity and has moderate to severe heart failure [New York Heart Association class III/IV] with reduced ejection fraction). [2010] Digoxin For recommendations on digoxin for people with atrial fibrillation, see the section on rate and rhythm control in NICE's guideline on atrial fibrillation. 1.4.11 Offer digoxin to people with worsening or
